Long‐term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer

PURPOSE: We examined the characteristics of breast cancer patients with oligometastases (OM) treated with stereotactic ablative body radiotherapy (SABR) to identify factors associated with local progression, distant metastasis progression, time to subsequent therapy, progression‐free survival (PFS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijetunga, N. Ari, dos Anjos, Carlos H., Zhi, W. Iris, Robson, Mark, Tsai, C. Jillian, Yamada, Yoshiya, Dover, Laura, Gillespie, Erin F., Xu, Amy J., Yang, Jonathan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335830/
https://www.ncbi.nlm.nih.gov/pubmed/34159748
http://dx.doi.org/10.1002/cam4.4068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335830/
https://www.ncbi.nlm.nih.gov/pubmed/34159748
http://dx.doi.org/10.1002/cam4.4068

Ejemplares similares